Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years. AMD affects the retinal pigment epithelium (RPE) and Bruch’s membrane in the macula, l...
প্রধান লেখক: | Borchert, GA, Shamsnajafabadi, H, Ng, BWJ, Xue, K, De Silva, SR, Downes, SM, MacLaren, RE, Cehajic-Kapetanovic, J |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
Frontiers Media
2024
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
অনুযায়ী: Grace A. Borchert, অন্যান্য
প্রকাশিত: (2024-07-01) -
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
অনুযায়ী: Grace A. Borchert, অন্যান্য
প্রকাশিত: (2023-08-01) -
Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
অনুযায়ী: Michelle E. McClements, অন্যান্য
প্রকাশিত: (2020-11-01) -
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
অনুযায়ী: Borchert, GA, অন্যান্য
প্রকাশিত: (2024) -
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy
অনুযায়ী: Hoda Shamsnajafabadi, অন্যান্য
প্রকাশিত: (2023-08-01)